For: | Yamamoto T, Yagi S, Kinoshita H, Sakamoto Y, Okada K, Uryuhara K, Morimoto T, Kaihara S, Hosotani R. Long-term survival after resection of pancreatic cancer: A single-center retrospective analysis. World J Gastroenterol 2015; 21(1): 262-268 [PMID: 25574100 DOI: 10.3748/wjg.v21.i1.262] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i1/262.htm |
Number | Citing Articles |
1 |
Lixia Wang, Srinivas Gaddam, Nan Wang, Yibin Xie, Zixin Deng, Zhengwei Zhou, Zhaoyang Fan, Tao Jiang, Anthony G. Christodoulou, Fei Han, Simon K. Lo, Ashley M. Wachsman, Andrew Eugene Hendifar, Stephen J. Pandol, Debiao Li. Multiparametric Mapping Magnetic Resonance Imaging of Pancreatic Disease. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00008
|
2 |
Masao Watanabe, Ryo Ashida, Chisato Miyakoshi, Shigeki Arizono, Tsuyoshi Suga, Shotaro Kanao, Koji Kitamura, Takahisa Ogawa, Reiichi Ishikura. Prognostic analysis of curatively resected pancreatic cancer using harmonized positron emission tomography radiomic features. European Journal of Hybrid Imaging 2023; 7(1) doi: 10.1186/s41824-023-00163-8
|
3 |
Zainab Jan, Farah El Assadi, Alaa Abd-alrazaq, Puthen Veettil Jithesh. Artificial Intelligence for the Prediction and Early Diagnosis of Pancreatic Cancer: Scoping Review. Journal of Medical Internet Research 2023; 25: e44248 doi: 10.2196/44248
|
4 |
Cole R. Drifka, Agnes G. Loeffler, Kara Mathewson, Adib Keikhosravi, Jens C. Eickhoff, Yuming Liu, Sharon M. Weber, W. John Kao, Kevin W. Eliceiri. Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection. Oncotarget 2016; 7(46): 76197 doi: 10.18632/oncotarget.12772
|
5 |
Takehito Yamamoto, Yoichiro Uchida, Hiroaki Terajima. Clinical impact of margin status on survival and recurrence pattern after curative-intent surgery for pancreatic cancer. Asian Journal of Surgery 2019; 42(1): 93 doi: 10.1016/j.asjsur.2017.09.003
|
6 |
Hussein Riyadh Abdul Kareem Al-Hetty, Sada Jasim Abdulameer, Sami Awad Alkubaisy, Sawsan Ali Zaid, Abduladheem Turki Jalil, Ihsan Khudhair Jasim. STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target. Pathology - Research and Practice 2023; 245: 154425 doi: 10.1016/j.prp.2023.154425
|
7 |
Tom Z. Liang, Matthew H. G. Katz, Laura R. Prakash, Deyali Chatterjee, Hua Wang, Michael Kim, Ching-Wei D. Tzeng, Naruhiko Ikoma, Robert A. Wolff, Dan Zhao, Eugene J. Koay, Anirban Maitra, Suprateek Kundu, Huamin Wang. Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy. Cancers 2023; 15(12): 3231 doi: 10.3390/cancers15123231
|
8 |
Stephan Altmayer, Larissa Maria Armelin, Jussara Soares Pereira, Lis Vitoria Carvalho, Justin Tse, Patricia Balthazar, Martina Zaguini Francisco, Guilherme Watte, Bruno Hochhegger. MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis. European Radiology 2023; 34(1): 106 doi: 10.1007/s00330-023-10069-5
|
9 |
Esteban Calderon, Ryan W. Day, Chee-Chee Stucky, Richard J. Gray, Barbara A. Pockaj, Yu-Hui Chang, Nabil Wasif. Comparative Effectiveness of Pylorus-Preserving Versus Standard Pancreaticoduodenectomy in Clinical Practice. Pancreas 2020; 49(4): 568 doi: 10.1097/MPA.0000000000001524
|
10 |
Masahide Ikeguchi, Takehiko Hanaki, Kanenori Endo, Kazunori Suzuki, Seiichi Nakamura, Takashi Sawata, Tetsu Shimizu. C-Reactive Protein/Albumin Ratio and Prognostic Nutritional Index Are Strong Prognostic Indicators of Survival in Resected Pancreatic Ductal Adenocarcinoma. Journal of Pancreatic Cancer 2017; 3(1): 31 doi: 10.1089/crpc.2017.0006
|
11 |
Lei Huang, Yesilda Balavarca, Lydia van der Geest, Valery Lemmens, Liesbet Van Eycken, Harlinde De Schutter, Tom B. Johannesen, Vesna Zadnik, Maja Primic-Žakelj, Margit Mägi, Robert Grützmann, Marc G. Besselink, Petra Schrotz-King, Hermann Brenner, Lina Jansen. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study . BMC Medicine 2019; 17(1) doi: 10.1186/s12916-019-1304-y
|
12 |
A. Adiamah, Z. Arif, F. Berti, S. Singh, N. Laskar, D. Gomez. The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta‐analysis of Randomised Controlled Trials. World Journal of Surgery 2019; 43(7): 1788 doi: 10.1007/s00268-019-04956-6
|
13 |
Richard Zheng, David Nauheim, Jonathan Bassig, Matthew Chadwick, Christopher W. Schultz, Geoffrey Krampitz, Harish Lavu, Jordan R. Winter, Charles J. Yeo, Adam C. Berger. Margin-Positive Pancreatic Ductal Adenocarcinoma during Pancreaticoduodenectomy: Additional Resection Does Not Improve Survival. Annals of Surgical Oncology 2021; 28(3): 1552 doi: 10.1245/s10434-020-09000-9
|
14 |
Sikandar Shaikh. Editorial for “Abbreviated Gadoxetic Acid‐Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma”. Journal of Magnetic Resonance Imaging 2022; 56(3): 737 doi: 10.1002/jmri.28054
|
15 |
Daniel Åkerberg, Daniel Ansari, Roland Andersson. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas. World Journal of Gastroenterology 2016; 22(28): 6424-6433 doi: 10.3748/wjg.v22.i28.6424
|
16 |
Dong Woo Shin, Jong-chan Lee, Jaihwan Kim, Yoo-Seok Yoon, Ho-Seong Han, Haeryoung Kim, Jin-Hyeok Hwang. Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resected pancreatic ductal adenocarcinoma: A biomarker stratified prospective trial. Pancreatology 2021; 21(4): 796 doi: 10.1016/j.pan.2021.02.022
|
17 |
Hao Gao, Tongtai Liu, Guangfu Wang, Yong Gao, Lingdi Yin, Yunpeng Peng, Nan Lyu, Kai Zhang, Wentao Gao, Junli Wu, Kuirong Jiang, Jishu Wei, Yi Miao. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case–control study. Langenbeck's Archives of Surgery 2019; 404(2): 175 doi: 10.1007/s00423-019-01766-1
|
18 |
Andrea Di Giorgio, Olivia Sgarbura, Stefano Rotolo, Carlo Alberto Schena, Cinzia Bagalà, Frediano Inzani, Andrea Russo, Vito Chiantera, Fabio Pacelli. Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma. Therapeutic Advances in Medical Oncology 2020; 12: 175883592094088 doi: 10.1177/1758835920940887
|
19 |
Ge Li, Cheng-Yu Liao, Jiang-Zhi Chen, Long Huang, Can Yang, Yi-Feng Tian, Yi-Ting Wang, Qiang Du, Qian Zhan, Yan-Ling Chen, Shi Chen. Construction and Validation of Novel Nomograms for Predicting Prognosis of Pancreatic Ductal Adenocarcinoma After Surgery According to Different Primary Cancer Locations. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.646082
|
20 |
Xiu‐Ping Zhang, Qinjunjie Chen, Qu Liu, Yang Wang, Fei Wang, Zhi‐Ming Zhao, Guo‐Dong Zhao, Wan Yee Lau, Yu‐Zhen Gao, Rong Liu. Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine 2021; 25(12): 5615 doi: 10.1111/jcmm.16573
|
21 |
R. Mantke, C. Schneider, K. Weylandt, S. Gretschel, F. Marusch, R. Kube, A. Loew, P. Jaehn, C. Holmberg, R. Hunger. Epidemiologie und operative Behandlung des Pankreaskarzinoms im Flächenland Brandenburg. Die Chirurgie 2022; 93(8): 788 doi: 10.1007/s00104-021-01561-z
|
22 |
Tinghai Xiang, Xiuliang Xia, Wenyan Yan. Expression of Matrix Metalloproteinases-2/-9 is Associated With Microvessel Density in Pancreatic Cancer. American Journal of Therapeutics 2017; 24(4): e431 doi: 10.1097/MJT.0000000000000424
|
23 |
Mary Acelle G. Garcia, Syed Imam, Ursula K. Braun, Leanne K. Jackson. Rational Prescribing of Pancreatic Enzymes for Patients with Pancreatic Cancer. Pharmacy 2024; 12(2): 47 doi: 10.3390/pharmacy12020047
|
24 |
Gong Zhang, Yuhao Kang, Haifeng Zhang, Fei Wang, Rong Liu. Robotic radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS): study protocol for a randomized controlled trial. Trials 2020; 21(1) doi: 10.1186/s13063-020-04250-0
|
25 |
Tanja Khosrawipour, Veria Khosrawipour, Urs Giger-Pabst, Wen-Lung Ma. Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma. PLOS ONE 2017; 12(10): e0186709 doi: 10.1371/journal.pone.0186709
|
26 |
Pan Gao, Aihua Dong, Bing Peng. Laparoscopic Surgery of the Spleen. 2021; : 113 doi: 10.1007/978-981-16-1216-9_10
|
27 |
A. A. Kovalev. ELECTROCHEMOTHERAPY IN THE TREATMENT OF UNRESECTABLE PANCREATIC CANCER. Modern medical technology 2022; (1): 40 doi: 10.34287/MMT.1(52).2022.8
|
28 |
Savio G Barreto, John A Windsor. Justifying vein resection with pancreatoduodenectomy. The Lancet Oncology 2016; 17(3): e118 doi: 10.1016/S1470-2045(15)00463-5
|
29 |
William T. Arscott, Kevin T. Nead, Adham Bear, Sriram Venigalla, Jacob Shabason, John N. Lukens, John P. Plastaras, Andrzej Wojcieszynski, James Metz, Mark O’Hara, Kim A. Reiss, Ursina Teitelbaum, Arturo Loaiza-Bonilla, Jeffrey Drebin, Major K. Lee, Stuti G. Shroff, Edgar Ben-Josef. Concurrent Nab-paclitaxel and Radiotherapy. American Journal of Clinical Oncology 2021; 44(9): 469 doi: 10.1097/COC.0000000000000854
|
30 |
Martin Lovecek, Pavel Skalicky, Dusan Klos, Linda Bebarova, Cestmir Neoral, Jiri Ehrmann, Jana Zapletalova, Hana Svebisova, Radek Vrba, Martin Stasek, Tharani Yogeswara, Roman Havlik. Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study. Biomedical Papers 2016; 160(2): 280 doi: 10.5507/bp.2016.011
|
31 |
Abdul Kareem Khan, Akriti Gupta Jain, Summia Afridi, Mohammed Wazir, Jana Srinivas Rao, Sarfraz Ahmad. Theranostic Approach for Pancreatic Cancer. 2019; : 111 doi: 10.1016/B978-0-12-819457-7.00006-2
|
32 |
L. Saikrishna, Prameswari Kasa, Saimila Momin, L. V. K. S. Bhaskar. Exploring Pancreatic Metabolism and Malignancy. 2019; : 157 doi: 10.1007/978-981-32-9393-9_9
|
33 |
Ge Li, Jiang‐Zhi Chen, Shi Chen, Sheng‐Zhe Lin, Wei Pan, Ze‐Wu Meng, Xin‐Ran Cai, Yan‐Ling Chen. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma. Cancer Medicine 2020; 9(10): 3353 doi: 10.1002/cam4.2959
|
34 |
Yingxue Wang, Zhihua Li, Shangyou Zheng, Yu Zhou, Lei Zhao, Huilin Ye, Xiaohui Zhao, Wenchao Gao, Zhiqiang Fu, Quanbo Zhou, Yimin Liu, Rufu Chen. Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. Oncotarget 2015; 6(34): 35684 doi: 10.18632/oncotarget.5533
|
35 |
Philipp Nitschke, Andreas Volk, Thilo Welsch, Jonas Hackl, Christoph Reissfelder, Mohammad Rahbari, Marius Distler, Hans-Detlev Saeger, Jürgen Weitz, Nuh N. Rahbari. Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic Cancer. Annals of Surgery 2017; 265(6): 1219 doi: 10.1097/SLA.0000000000001808
|
36 |
Lydia Mok, Yongkang Kim, Sungyoung Lee, Sungkyoung Choi, Seungyeoun Lee, Jin-Young Jang, Taesung Park. HisCoM-PAGE: Hierarchical Structural Component Models for Pathway Analysis of Gene Expression Data. Genes 2019; 10(11): 931 doi: 10.3390/genes10110931
|
37 |
Anne E. O’Shea, Phillip M. Kemp Bohan, Elizabeth L. Carpenter, Patrick M. McCarthy, Alexandra M. Adams, Robert C. Chick, Julia O. Bader, Robert W. Krell, George E. Peoples, Guy T. Clifton, Daniel W. Nelson, Timothy J. Vreeland. Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. Annals of Surgical Oncology 2022; 29(9): 6015 doi: 10.1245/s10434-022-11800-0
|
38 |
Honam Hwang, Hongbeom Kim, Hee Ju Sohn, Mirang Lee, Hyeong Seok Kim, Youngmin Han, Wooil Kwon, Jin-Young Jang. Stool Elastase as an Independent Prognostic Factor in Patients with Pancreatic Head Cancer. Journal of Clinical Medicine 2022; 11(13): 3718 doi: 10.3390/jcm11133718
|
39 |
Yu-Jen Cheng, Yen-Chun Liu, Chang-Yu Tsai, Chiung-Yu Huang. Semiparametric Estimation of the Transformation Model by Leveraging External Aggregate Data in the Presence of Population Heterogeneity. Biometrics 2023; 79(3): 1996 doi: 10.1111/biom.13778
|
40 |
Juraj Prejac, Dora Tomek Hamzić, Nikša Librenjak, Irma Goršić, Domina Kekez, Stjepko Pleština. The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence. Medicine 2022; 101(39): e30566 doi: 10.1097/MD.0000000000030566
|
41 |
Masahide Ikeguchi, Takehiko Hanaki, Kanenori Endo, Kazunori Suzuki, Seiichi Nakamura, Takashi Sawata, Tetsu Shimizu. C-Reactive Protein/Albumin Ratio and Prognostic Nutritional Index Are Strong Prognostic Indicators of Survival in Resected Pancreatic Ductal Adenocarcinoma. Journal of Pancreatic Cancer 2017; 3(1): 31 doi: 10.1089/pancan.2017.0006
|
42 |
Debang Li, Bin Hu, Yanming Zhou, Tao Wan, Xiaoying Si. Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4901-9
|
43 |
Tadashi Odagiri, Yoshiya Asano, Takuji Kagiya, Michiya Matsusaki, Mitsuru Akashi, Hiroshi Shimoda, Kenichi Hakamada. The Cell Line-Dependent Diversity in Initial Morphological Dynamics of Pancreatic Cancer Cell Peritoneal Metastasis Visualized by an Artificial Human Peritoneal Model. Journal of Surgical Research 2021; 261: 351 doi: 10.1016/j.jss.2020.12.046
|
44 |
Milena Ilic, Irena Ilic. Epidemiology of pancreatic cancer. World Journal of Gastroenterology 2016; 22(44): 9694-9705 doi: 10.3748/wjg.v22.i44.9694
|
45 |
Lukuan You, Jinliang Wang, Fan Zhang, Jing Zhang, Haitao Tao, Xuan Zheng, Yi Hu. Potential four‑miRNA signature associated with T�stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9663
|
46 |
Biqi Zhang, Grace C. Lee, Motaz Qadan, Zhi Ven Fong, Mari Mino-Kenudson, Vikram Desphande, Giuseppe Malleo, Laura Maggino, Giovanni Marchegiani, Roberto Salvia, Aldo Scarpa, Claudio Luchini, Lucia De Gregorio, Cristina R. Ferrone, Andrew L. Warshaw, Keith D. Lillemoe, Claudio Bassi, Carlos Fernández-del Castillo. Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma. Annals of Surgery 2021; 274(2): e134 doi: 10.1097/SLA.0000000000003503
|
47 |
Bin Li, Michael S. Nelson, Omid Savari, Agnes G. Loeffler, Kevin W. Eliceiri. Differentiation of pancreatic ductal adenocarcinoma and chronic pancreatitis using graph neural networks on histopathology and collagen fiber features. Journal of Pathology Informatics 2022; 13: 100158 doi: 10.1016/j.jpi.2022.100158
|
48 |
Ammar A. Javed, Omar Mahmud, Asad Saulat Fatimi, Alyssar Habib, Mahip Grewal, Jin He, Christopher L. Wolfgang, Marc G. Besselink. Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology 2024; 31(7): 4673 doi: 10.1245/s10434-024-15281-1
|
49 |
Axel Bengtsson, Roland Andersson, Daniel Ansari. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73525-y
|
50 |
Han-xiang Zhan, Yao Wang, Ce Li, Jian-wei Xu, Bin Zhou, Jian-kang Zhu, Hai-feng Han, Lei Wang, Yun-shan Wang, San-yuan Hu. LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway. Cancer Letters 2016; 374(2): 261 doi: 10.1016/j.canlet.2016.02.018
|
51 |
Rong Lin, Chao-qun Han, Wei-jun Wang, Jun Liu, Wei Qian, Zhen Ding, Xiao-hua Hou. Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma. Journal of Huazhong University of Science and Technology [Medical Sciences] 2017; 37(4): 612 doi: 10.1007/s11596-017-1780-2
|
52 |
So Jeong Yoon, Sang Hyun Shin, So Kyung Yoon, Ji Hye Jung, Yunghun You, In Woong Han, Dong Wook Choi, Jin Seok Heo. Appraisal of 5‐year recurrence‐free survival after surgery in pancreatic ductal adenocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2021; 28(3): 287 doi: 10.1002/jhbp.815
|
53 |
R. V. Ischenko, Yu. V. Ivanov, A. V. Smirnov, V. N. Antipov. Surgical Strategy in Patients with Complete Transposition of Internal Organs in Cancer of the Biliopancreatoduodenal Zone. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 33(3): 76 doi: 10.22416/1382-4376-2023-33-3-76-84
|
54 |
Aslam Syed, Olivia Babich, Bharat Rao, Shailendra Singh, Neil Carleton, Abhishek Gulati, Archana Kulkarni, Mrinal Garg, Katie Farah, Gursimran Kochhar, Suzanne Morrissey, Marcia Mitre, Abhijit Kulkarni, Manish Dhawan, Jan F. Silverman, Majed Pharaon, Shyam Thakkar. Endoscopic ultrasound guided fine‐needle aspiration vs core needle biopsy for solid pancreatic lesions: Comparison of diagnostic accuracy and procedural efficiency. Diagnostic Cytopathology 2019; 47(11): 1138 doi: 10.1002/dc.24277
|
55 |
Naoya Kasahara, Hiroshi Noda, Nao Kakizawa, Takaharu Kato, Fumiaki Watanabe, Kosuke Ichida, Yuhei Endo, Hidetoshi Aizawa, Toshiki Rikiyama. A lack of postoperative complications after pancreatectomy contributes to the long-term survival of patients with pancreatic cancer. Pancreatology 2019; 19(5): 686 doi: 10.1016/j.pan.2019.06.012
|
56 |
Masahide Ikeguchi, Keisuke Goto, June Watanabe, Shoichi Urushibara, Tomohiro Osaki, Kanenori Endo, Shigeru Tatebe, Seiichi Nakamura. Clinical importance of preoperative and postoperative prognostic nutritional index in patients with pancreatic ductal adenocarcinoma. Annals of Hepato-Biliary-Pancreatic Surgery 2019; 23(4): 372 doi: 10.14701/ahbps.2019.23.4.372
|
57 |
Jongkwang Kim, Sumok Bae, Seong-Mi Yoon, Sungmoon Jeong. Roadmap for providing and leveraging annotated data by cytologists in the PDAC domain as open data: support for AI-based pathology image analysis development and data utilization strategies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1346237
|
58 |
Anna Melissa Schlitter, Moritz Jesinghaus, Carsten Jäger, Björn Konukiewitz, Alexander Muckenhuber, Ihsan Ekin Demir, Marcus Bahra, Carsten Denkert, Helmut Friess, Günter Kloeppel, Güralp O. Ceyhan, Wilko Weichert. pT but not pN stage of the 8th TNM classification significantly improves prognostication in pancreatic ductal adenocarcinoma. European Journal of Cancer 2017; 84: 121 doi: 10.1016/j.ejca.2017.06.034
|
59 |
Monika Karpińska, Marian Czauderna. Pancreas—Its Functions, Disorders, and Physiological Impact on the Mammals’ Organism. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.807632
|
60 |
Weiyu Ge, Jingyu Ma, Tiebo Mao, Haiyan Xu, Xiaofei Zhang, Shumin Li, Yongchao Wang, Jiayu Yao, Ming Yue, Feng Jiao, Yu Wang, Meng Zhuo, Ting Han, Jiong Hu, Xiao Zhang, Jiujie Cui, Liwei Wang. Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.890715
|
61 |
Moon Hyung Choi, Young Joon Lee, Seung Bae Yoon, Joon-Il Choi, Seung Eun Jung, Sung Eun Rha. MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcome. Abdominal Radiology 2019; 44(1): 122 doi: 10.1007/s00261-018-1681-2
|
62 |
Winta T. Mehtsun, Daniel A. Hashimoto, Cristina R. Ferrone. Status of 5-Year Survivors of the Whipple Procedure for Pancreatic Adenocarcinoma. Advances in Surgery 2019; 53: 253 doi: 10.1016/j.yasu.2019.04.012
|
63 |
Hartwig Riediger, Birte Kulemann, Uwe Wittel, Ulrich Adam, Olivia Sick, Hannes Neeff, Jens Höppner, Ulrich T. Hopt, Frank Makowiec. Prognostic Role of Log Odds of Lymph Nodes After Resection of Pancreatic Head Cancer. Journal of Gastrointestinal Surgery 2016; 20(10): 1707 doi: 10.1007/s11605-016-3200-5
|
64 |
Sultan F. Kadasah, Abdulmajeed F. Alrefaei, Harbi A. Ali. Efficacy of Prunus armenica, Bee venom, and their combinations on p53 and Bcl-2 gene expression in human pancreatic and lung cancer cells. Journal of Umm Al-Qura University for Applied Sciences 2023; 9(4): 487 doi: 10.1007/s43994-023-00058-1
|
65 |
Mazhar A. Kanak, Yoshitaro Shindo, Pavithra SaiKumar, Bashoo Naziruddin. Inflammasomes: Clinical and Therapeutic Implications. Experientia Supplementum 2018; 108: 235 doi: 10.1007/978-3-319-89390-7_10
|
66 |
Simon Gray, Nicola de Liguori Carino, Ganesh Radhakrishna, Angela Lamarca, Richard A. Hubner, Juan W. Valle, Mairéad G. McNamara. Clinical challenges associated with utility of neoadjuvant treatment in patients with pancreatic ductal adenocarcinoma. European Journal of Surgical Oncology 2022; 48(6): 1198 doi: 10.1016/j.ejso.2022.02.014
|
67 |
Jin Hong Lim, Joon Seong Park, Dong Sup Yoon. Preoperative fecal elastase-1 is a useful prognostic marker following curative resection of pancreatic cancer. HPB 2017; 19(5): 388 doi: 10.1016/j.hpb.2016.12.007
|
68 |
媛媛 苏. Effects of Radiotherapy and Chemotherapy on Postoperative Prognosis of Patients Undergoing Radical Surgery for Pancreatic Cancer—Based on SEER Database Analysis. Advances in Clinical Medicine 2022; 12(10): 9540 doi: 10.12677/ACM.2022.12101380
|
69 |
Christos Svoronos, Georgios Tsoulfas, Maria Souvatzi, Efthimios Chatzitheoklitos. Prognostic value of COL6A3 in pancreatic adenocarcinoma. Annals of Hepato-Biliary-Pancreatic Surgery 2020; 24(1): 52 doi: 10.14701/ahbps.2020.24.1.52
|
70 |
Apostolos Gaitanidis, Michail Alevizakos, Alexandra Tsaroucha, Christos Tsalikidis, Constantinos Simopoulos, Michail Pitiakoudis. Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection. European Journal of Surgical Oncology 2018; 44(5): 693 doi: 10.1016/j.ejso.2018.01.011
|
71 |
Hee Ju Sohn, Hongbeom Kim, Sun Joo Kim, Kyung Bun Lee, Youngmin Han, Jung Min Lee, Jae Seung Kang, Wooil Kwon, Eui Kyu Chie, Haeryoung Kim, Jin-Young Jang. Oncologic outcomes according to the location and status of resection margin in pancreas head cancer: role of radiation therapy in R1 resection. Annals of Surgical Treatment and Research 2022; 102(1): 10 doi: 10.4174/astr.2022.102.1.10
|
72 |
Shuisheng Zhang, Xiaozhun Huang, Yuan Tian, Saderbieke Aimaiti, Jianwei Zhang, Jiuda Zhao, Yingtai Chen, Chengfeng Wang. Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China. PeerJ 2018; 6: e4893 doi: 10.7717/peerj.4893
|
73 |
Han‐Xiang Zhan, Jian‐Wei Xu, Dong Wu, Zhi‐Yang Wu, Lei Wang, San‐Yuan Hu, Guang‐Yong Zhang. Neoadjuvant therapy in pancreatic cancer: a systematic review and meta‐analysis of prospective studies. Cancer Medicine 2017; 6(6): 1201 doi: 10.1002/cam4.1071
|
74 |
Pranav Murthy, Mazen S. Zenati, Amr I. Al Abbas, Caroline J. Rieser, Nathan Bahary, Michael T. Lotze, Herbert J. Zeh, Amer H. Zureikat, Brian A. Boone. Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer. Annals of Surgical Oncology 2020; 27(3): 898 doi: 10.1245/s10434-019-08094-0
|
75 |
Evan S. Glazer, Omar M. Rashid, Jose M. Pimiento, Pamela J. Hodul, Mokenge P. Malafa. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma. Surgery 2016; 160(5): 1288 doi: 10.1016/j.surg.2016.04.039
|
76 |
Tadataka Takagi, Minako Nagai, Satoshi Nishiwada, Taichi Terai, Satoshi Yasuda, Yasuko Matsuo, Shunsuke Doi, Yuichiro Kohara, Masayuki Sho. Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma. Annals of Gastroenterological Surgery 2023; 7(2): 326 doi: 10.1002/ags3.12629
|
77 |
Qiancheng Hu, Dan Wang, Ye Chen, Xiaofen Li, Peng Cao, Dan Cao. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma. Radiation Oncology 2019; 14(1) doi: 10.1186/s13014-019-1330-0
|
78 |
Evan S. Glazer, Omar M. Rashid, Jason B. Klapman, Cynthia L. Harris, Pamela J. Hodul, Jose M. Pimiento, Mokenge P. Malafa. Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma. Pancreatology 2017; 17(1): 130 doi: 10.1016/j.pan.2016.12.001
|
79 |
Stefano Rotolo, Federica Ferracci, Francesco Santullo, Claudio Lodoli, Frediano Inzani, Carlo Abatini, Fabio Pacelli, Andrea Di Giorgio. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A case report of a multimodal treatment for peritoneal metastases of pancreatic origin. International Journal of Surgery Case Reports 2020; 77: S75 doi: 10.1016/j.ijscr.2020.10.054
|
80 |
Seung Baek Hong, Seung Soo Lee, Jin Hee Kim, Hyoung Jung Kim, Jae Ho Byun, Seung Mo Hong, Ki-Byung Song, Song Cheol Kim. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria. Radiology 2018; 289(3): 710 doi: 10.1148/radiol.2018180628
|